Trial Profile
A real-world, observational study of ipilimumab in patients with metastatic melanoma from a pan-Canadian registry - The Canadian Melanoma Research Network (CMRN)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Dec 2016
Price :
$35
*
At a glance
- Drugs Ipilimumab (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 03 Dec 2016 New trial record